Results 101 to 110 of about 15,991 (171)

Cryo-EM structure of the tissue factor/factor VIIa complex with a factor X mimetic reveals a novel allosteric mechanism. [PDF]

Blood
Sedzro JC, Photenhauer AL, Birkle F, Meze K, Mortenson A, Duckworth C, Wen PC, Kearns S, Cianfrocco MA, Tajkhorshid E, Ohi MD, Morrissey JH.   +11 more
europepmc   +1 more source

Subcutaneous engineered factor VIIa marzeptacog alfa (activated) in hemophilia with inhibitors: Phase 2 trial of pharmacokinetics, pharmacodynamics, efficacy, and safety. [PDF]

Res Pract Thromb Haemost, 2021
Mahlangu J, Levy H, Kosinova MV, Khachatryan H, Korczowski B, Makhaldiani L, Iosava G, Lee M, Del Greco F.   +8 more
europepmc   +1 more source

Outcomes of recombinant activated factor VIIa (NovoSeven) therapy in glanzmann thrombasthenia: two case reports. [PDF]

Blood Coagul Fibrinolysis
Almatar E, Alsharidah S, Hashem OA.
europepmc   +1 more source

Factor VIIa suppresses inflammation and barrier disruption through the release of EEVs and transfer of microRNA 10a.

Blood, 2022
Das K, Keshava S, Pendurthi UR, Rao LVM.
europepmc   +1 more source

Successful Desensitization Protocol in an Infant Following Anaphylaxis Secondary to Recombinant Factor VIIa. [PDF]

Pediatr Allergy Immunol Pulmonol, 2020
Ulusoy Severcan E, Cigerci Gunaydin N, Hekimci Ozdemir H, Gulen F, Kavakli K, Tanac R, Demir E.   +6 more
europepmc   +1 more source

Use of recombinant factor VIIa in orthotopic liver transplant

Indian Journal of Anaesthesia, 2011
Pradeep Bhatia
doaj   +1 more source

Recombinant Activated Factor VIIa Combined With Tranexamic Acid Control Haemostasis in Patients With Severe Factor XI Deficiency Undergoing Urological Procedures. [PDF]

Haemophilia
Sternbach N, Ehrlich Y, Stenevsky A, Saidian D, Elhalim DA, Baniel J, Raanani P, Spectre G.   +7 more
europepmc   +1 more source

Conformational Plasticity-Rigidity Axis of the Coagulation Factor VII Zymogen Elucidated by Atomistic Simulations of the N-Terminally Truncated Factor VIIa Protease Domain. [PDF]

Biomolecules, 2021
Madsen JJ, Olsen OH.
europepmc   +1 more source

Good metabolic control is associated with decreased circulating factor VIIa- antithrombin complexes in type 2 diabetes: a cross-sectional study. [PDF]

Cardiovasc Diabetol
Gastoł J, Paszek E, Bryk-Wiązania A, Matejko B, Undas A.   +4 more
europepmc   +1 more source

Efficacy and Safety Analyses of Recombinant Factor VIIa in Severe Post-Partum Hemorrhage. [PDF]

J Clin Med
Caram-Deelder C, McKinnon Edwards H, Zdanowicz JA, van den Akker T, Birkegård C, Blatný J, van der Bom JG, Colucci G, van Duuren D, van Geloven N, Henriquez DDCA, Knight M, Korsholm L, Landorph A, Lavigne Lissalde G, McQuilten ZK, Surbek D, Wellard C, Wood EM, Mercier FJ.   +19 more
europepmc   +1 more source